FindTrial
Sign In

Prognosis and Recurrence Risk Analysis of Pediatric Myasthenia Gravis

Prognosis and Recurrence Risk Analysis of Pediatric Myasthenia Gravis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128127
Enrollment
Unknown
Registered
2026-07-14
Start date
2026-07-15
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myasthenia gravis

Interventions

Pre-adolescent group& adolescent group:None

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1.The onset age ranges from 0 to 18 years old; 2.The patient was clinically diagnosed with myasthenia gravis; 3. Parents or guardians agree to participate in this study.

Exclusion criteria

Exclusion criteria: 1.Combined with other neurological disorders or severe internal medical conditions; 2.Unable to conduct long-term follow-up.

Design outcomes

Primary

MeasureTime frame
Recurrence rate;—

Secondary

MeasureTime frame
Disease Remission Rate;Quality of life score;Number of hospital stays;—

Countries

China

Contacts

Public ContactBaomin Li

Qilu Hospital of Shandong University

lbmsqf@163.com+86 531 82165951

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026